Basic net income (loss) per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during the period. In computing diluted net income per share, the sum of the weighted-average number of shares of common stock outstanding during the period is used and only when their effect is dilutive, the weighted-average number of potential shares of common stock are included. In June 2019, the Company sold 422,718 shares of common stock and pre-funded warrants to purchase an aggregate of 169,874 shares of common stock at an exercise price of $135 per share, with $134.85 of such exercise price paid at the closing of the offering (see Note 8, Stockholders' Equity, in the audited financial statements included in the 2025 Annual Report). The shares of common stock into which the warrants may be exercised are considered outstanding for the purposes of computing net loss per share.

Basic and diluted EPS for the three and six months ended June 30, 2026 and 2025 were calculated as follows (in thousands, except share and per share data):


	Three Months Ended June 30,						Six Months Ended June 30,
	2026			2025			2026		2025
Numerator:
Net income (loss)	$	(543	)	$	(529	)	$	138	$	(212	)
Denominator:
Basic weighted-average common shares outstanding		12,418,592			12,319,147			12,406,266		12,301,476
Effect of dilutive securities		—			—			783		—
Diluted weighted-average common shares outstanding		12,418,592			12,319,147			12,407,049		12,301,476

Basic and Diluted EPS	$	(0.04	)	$	(0.04	)	$	0.01	$	(0.02	)

The following potential shares of common stock, presented based on amounts outstanding at each period end, were excluded from the calculation of the diluted net loss per share attributable to common stockholders for the period indicated, because including them would have had an anti-dilutive effect.


	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Purchase warrants		7,394,363		7,394,363		7,394,363		7,394,363
Unvested restricted common stock awards		226		101,896		—		101,896
Outstanding options to purchase common stock		230,530		289,030		230,530		289,030
		7,625,119		7,785,289		7,624,893		7,785,289